zeneca zd 6169 has been researched along with sodium dichloroacetate in 1 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (sodium dichloroacetate) | Trials (sodium dichloroacetate) | Recent Studies (post-2010) (sodium dichloroacetate) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 19 | 0 | 13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aicher, TD; Anderson, RC; Bebernitz, GR; Brand, LJ; Coppola, GM; DelGrande, D; Dragland, C; Gao, J; Islam, A; Jewell, CF; Kaplan, EL; Knorr, DC; Liu, C; Liu, X; Lozito, RJ; Maniara, WM; Mann, WR; Shetty, SS; Sperbeck, DM; Strohschein, RJ; Vinluan, CC; Walter, RE | 1 |
1 other study(ies) available for zeneca zd 6169 and sodium dichloroacetate
| Article | Year |
|---|---|
(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase.
Topics: Administration, Oral; Amides; Animals; Enzyme Inhibitors; Fibroblasts; Humans; In Vitro Techniques; Lactic Acid; Propionates; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Stereoisomerism; Structure-Activity Relationship | 1999 |